Takeaway: Alpha-gal to provoke tumor rejection

Avi summarizes that alpha-gal–expressing oncolytic viruses may induce hyperacute tumor rejection and merit further trials.

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!